UNIGE scientists developed an algorithm able to anticipate the risk of cancer metastasis and recurrence. Group of human colon ...

Published on UNIGE scientists developed an algorithm able to anticipate the risk of cancer metastasis and recurrence. Group of human colon ...

A new consensus document developed by The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium was published in JCO ...

Underlying causes of recurrent pneumonia in children have changed in the last decade, indicating a need for individualized diagnostic approaches.

Intismeran autogene with pembrolizumab shows a 49% reduction in recurrence or death risk in patients with high-risk resected melanoma over 5 years. The personalized mRNA therapy targets ...

Johns Hopkins biomedical engineers Ishan Vatsaraj, Stanley Chun Ming Wu, and Jaemyung Shin have been awarded highly ...

Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the ...

For many women with early breast cancer, surgery is effective but life-altering. New five-year data from the National Institutes for Quantum Science and Technology (QST) suggest that a precisely ...

AI chip startup Etched.ai has reportedly raised $500 million in a funding round that was led by investment firm Stripes and ...

Published in JCO Precision Oncology, the new analytical validation standards offer an industry-wide protocol for test developersCHICAGO, Jan. 15, 2026 /PRNewswire/ -- A new consensus document ...

Report considers where investors should pivot next, the breakthrough themes steering the 2026 innovation wave.

A prospective phase I/II clinical trial led by QST Hospital reports that carbon-ion radiotherapy achieved five-year local control and disease-free survival rates of 92%, with no grade ≥2 toxicities, ...